A. Rossi , R. Pollice - Vol. 5, Giugno 1999, num.2
Testo Immagini Bibliografia Summary Riassunto Indice
1 American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV).
Washington DC: American Psychiatric Association 1994.
2 Bellak L.
Comorbidity of attention deficit hyperactivity disorder and other disorders.
American Journal of Psychiatry 1992;149;147-148.
3 Shaffer D.
Attention-deficit/hyperactivity disorder in adults.
American Journal of Psychiatry 1994;151:633-638.
4 Zametkin AJ
Attention deficit disorder. Born to be Hyperactive?
Journal of the American Medical Association 1995;273:1871-1875.
5 Roy-Byrne P, Scheele L, Ward N, Wiatraks C, Russo J, Townes B, e Coll.
Adult Attention-deficit hyperactivity disorder: assessment guidelines based
on clinical presentation to a specially clinic.
Comprehensive Psychiatry 1997;38:133-140.
6 Miller K.
Attention deficit disorder affects adults, but some doctors question how
widely.
The Wall Street Journal 1993, January 11.
7 Wallis C.
An epidemic of attention deficit disorder.
Time 1994, July 18.
8 Hallowell EM, Ratey JJ.
Driven to Distraction - Recognizing and coping with Attention Deficit Disorder
from Childhood through Adulthood.
New York: Touchstone 1994.
9 Kilcarr P, Quinn PO.
Voices from fatherhood. Fathers, sons and ADHD
Philadelphia: Brunner/Mazel eds 1997.
10 Nadeau KG.
Add in the workplace. Choise, Changes and Challenges.
Philadelphia: Brunner/Mazel 1997.
11 Cohen MW.
The attention zone. A parents guide to Attention Deficit/Hyperactivity
Disorder.
Philadelphia: Brunner/Mazel 1997.
12 Spencer T, Wilens T, Biederman J.
Tryciclic antidepressant treatment of hyperactivity.
Current Opinion in Psychiatry 1994;7:304-307.
13 Zametkin AJ, Nordahl TE, Gross M, e Coll.
Cerebral glucose metabolism in adults with hyperactivity of childhood onset.
New England Journal of Medicine 1990;323:1361-1366.
14 Faraone SV, Biederman J, Keenan K, e Coll.
A family genetic study of girls with DSM-III attention deficit disorder.
American Journal of Psychiatry 1991;148:112-117.
15 Biederman J, Faraone SV, Keenan K, e Coll.
Further evidence for family-genetic risk factors in attention deficit hyperactivity
disorder: patterns of comorbidity in probands and relatives in psychiatrically
and pediatrically referred samples.
Archives of General Psychiatry 1992;49:728-738.
16 Deutsch CK, Swanson JM, Bruell JH, e Coll.
Over representation of adoptees in children with the attention deficit
disorder.
Behavior Genetics 1992;12:231-238.
17 Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang T.
Attention-deficit/hyperactivity disorder and comorbid disorders: issues
of overlapping symptoms.
American Journal of Psychiatry 195;152:1793-1799.
18 Bonn D.
Methylphenidate: US and European views converging?
Lancet 1996;348:255.
19 Sloan D.
Attention deficit hyperactivity disorder needs to be recognised.
BMJ 1997;315:312.
20 Sergeant J, Steinhausen HC.
European perspectives on hyperkinetic disorder.
European Child and Adolescent Psychiatry 1992;1:34-41.
21 Gallucci F, Bird HR, Berardi C, Gallai V, Pfanner P, Weinberg A.
Symptoms of Attention-deficit hyperactivity disorder in an Italian school
sample: findings of a pilot study.
Journal of the American Academy of Child and Alolescent Psychiatry 1993;32:1051-1058.
22 Wender PH.
The Hyperactive Child, Adolescent, and Adult: Attention Deficit Disorder
Through the Lifespan.
New York: Oxford University Press 1987.
23 Berry CA, Sharwtiz SE, Shaywitz BA.
Girls with attention deficit disorder: a silent minority? A report on behavioral
and cognitive characteristics.
Pediatrics 1985;76:801- 809.
24 Toone BK e Van Der Linden GJH.
Attention-deficit hyperactivity disorder or hyperkinetic disorder in adults.
British Journal of Psychiatry 1997;170:489-491.
25 Wender PH, Reimherr FW, Wood DR, e Coll.
A controlled study of methylphenidate in the treatment of attention deficit
disorder, residual type, in adults.
American Journal of Psychiatry 1985;142:547-552.
26 Conners CK.
Conners ADHD/DSM-IV Scales (CADS).
North Tanawanda, NY: MHS, eds 1997.
27 Edelbrock C.
Behavioral checklists and rating scales.
In: Cali ID, Cohen RL, Harrison SI, e Coll. Basic Handbook of
Child Psychiatry. New York: Basic Books 1987:153-164.
28 Barkley RA, ed, Cali ID, Cohen RL, Harrison SI, e Coll.
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and
Treatment.
New York: Guilford 1990.
29 Triolo SJ.
Attention-Deficit Scales for Adults (ADSA).
Philadelphia: Brunner/Mazel eds 1995.
30 Brown TE.
Brown Attention-Deficit Disorders Scales (Brown ADD Scales). The Psychological
Corporation.
San Antonio: Harcourt Brace & Company 1996.
31 Rossi A, Stratta P.
Psicologia e patologia dellattenzione.
In: Trattato Italiano di Psichiatria. Milano: Masson 1999.
32 Biederman J, Newcorn J, Sprich S.
Comorbidity attention deficit hyperactivity disorder with conduct, depressive,
anxiety and other disorders.
American Journal of Psychiatry 1991;148:564-577.
33 West SA, McErloy SL, Strakowski SM, Keck PE jr, McConville B.
Attention-deficit/hyperactivity disorder in adolescent mania.
American Journal of Psychiatry 1995;152:271-273.
34 Geller B, Luby J.
Child and adolescent bipolar disorder: A review of the past 10 years.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1168-1176.
35 Faraone SV, Biederman J, Jetton JG, Tsuang MT.
Attention deficit disorder and conduct disorder - longitudinal evidence
for a familial subtype.
Psychological Medicine 1997;27(2):291-300.
36 Biederman J, Faraone SV, Mick E, Wozniak J, Chen L, Ouellette C, e Coll.
Attention deficit hyperactivity disorder and juvenile mania: an overlooked
comorbidity?
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:997-1008.
37 Geller B, Sun K, Zimerman B, Luby J, Frazier J, Williams M.
Complex and rapid-cycling in bipolar children and adolescent: a preliminary
study.
Journal of Affective Disorders 1995;34:259-268.
38 Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, e Coll.
Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically
referred children.
Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:867-876.
39 West SA, Strakowski SM, Sax KW, Minnery KL, McErloy SL, Keck PE Jr.
The comorbidity of attention-deficit/hyperactivity disorder in adolescent
mania: potential diagnostic and treatment implications.
Psychopharmacology Bulletin 1995;31:347-351.
40 Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA.
Hyperactive boys almost grown up: V. Replication of psychiatric status.
Archives of General Psychiatry 1991;48:77-83.
41 Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M.
Adult outcome of hyperactive boys: educational achievment, occupational
rank, and psychiatric status.
Archives of General Psychiatry 1993;50:565-576.
42 Dulcan M.
Pratice parameters for the assessment and treatment of children, adolescents
and adults with Attention-Deficit/Hyperactivity Disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36(Suppl):85-113.
43 Porrino LJ, Rapoport JL, Behar D, e Coll.
A naturalistic assessment of the motor activity of hyperactive boys, I:
comparison with normal controls.
Archives of General Psychiatry 1983;40:681-687.
44 Sandberg S.
Hyperkinetic or attention deficit disorder.
British Journal Psychiatry 1996;169:10-17.
45 Lahey BB, Schaughency EA, Hynd GW, e Coll.
Attention deficit disorder with and without hyperactivity: comparison of
behavioural characteristics of clinic-referred children.
Journal of the American Academy of Child and Adolescent Psychiatry 1987;26:718-723.
46 Famularo R, Fenton T.
The effect of methylphenidate on school grades in children with attention
deficit disorder without hyperactivity: a preliminary report.
Journal of Clinical Psychiatry 1987;48:112-114.
47 Gittelman R, Mannuzza S, Shenker R, e Coll.
Hyperactive boys almost grown up, I: psychiatric status.
Archives of General Psychiatry 1985;42:937-947.
48 Weiss C, Hechtman LT.
Hyperactive Children Grown Up: Empirical Findings and Theoretical Considerations.
New York: Guilford 1986.
49 Hill JC, Schoener P.
Age-dependent decline of attention-deficit/hyperactivity disorder.
American Journal of Psychiatry 1996;153:1143-1147.
50 Slomkowsky C, Klein RG, Mannuzza S.
Is self-esteem an important outcome in hiperactive children?
Journal of Abnormal Child Psychology 1995;23:303-315.
51 Biederman J, Mick E, Faraone SV.
Normalized functioning in youths with persistent attention-deficit/hyperactivity
disorder.
Journal of Pediatrics 1998;133:544-551.
52 Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME.
Educational and occupational outcome of hyperactive boys grown up.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1222-1227.
53 Riccio CA, Hynd GJ, Cohen MJ, Hall J, Molt L.
Comorbidity of central auditory processing disorder and Attention-deficit
hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:849-857.
54 DuPaul GJ, Barkley RA, McCurray MB.
Response of children with ADHD to metylphenidate: interactions with internalizing
symptoms.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:894-903.
55 Rapport MD, Denney C, DuPaul GJ, Gardner MJ.
Attention deficit disorder and methylphenidate: normalization rates, clinical
effectiveness, and response prediction in 76 children.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:888-893.
56 Gross-Tsur V, Manor O, Van der Meere J, Joseph A, Shalev RS.
Epilepsy and attention deficit hyperactivity disorder: is metylphenidate
safe and effective?
Journal of Pediatrics 1997;130:670-675.
57 Faraone SV, Biederman J, Mennin D, Woozniak J, Mundy E, Mennin D, e Coll.
Comorbidity with ADHD a marker for juvenile-onset mania?
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1046-1055.
58 Biederman J, Faraone SV, Keenan K, Tsuang MT.
Evidence of familial association between attention deficit disorder and
major affective disorders.
Archives of General Psychiatry 1991;48:633-642.
59 August GJ, Stewart MA, Holmes CS.
A four-year follow-up of hyperactive boys with and without conduct disorder.
British Journal of Psychiatry 1983;143:192-198.
60 Achenbach TM, Edelbrock C.
Manual for the Child Behavioural Checklist and Revised Child Behavioural
Profile.
Burlington, VT: University of Vermont Psychology Department 1983.
61 Marcus J, Hans SL, Mednick SA, e Coll.
Neurological dysfunctioning in offspring of schizophrenics in Israel and
Denmark: a replication analysis.
Archives General of Psychiatry 1985;42:753-761.
62 Hauser P, Zametkin AJ, Martinez P, e Coll.
Attention deficit-hyperactivity disorder in people with generalized resistance
to thyroid hormone.
New England Journal of Medicine 1993;328:997-1001.
63 Valentine J, Rossi E, Oleary P, Parry TS, Kurinczuz JJ.
Thyroid function in a population of children with attention deficit hyperactivity
disorder.
Journal of Pediatrics and Child Health 1997;33:117-120.
64 Landgren M, Kjellman B, Gillberg C.
Attention deficit disorder with developmental coordination disorders.
Archives of Diseases of the Child 1998;79:207-212.
65 Blum K;Cull JG, Braverman ER, Comings DE.
Reward deficency syndrome.
American Scientist 1996;84:132-145.
66 Carlson GA.
Compared to attention-deficit/hyperactivity disorder.
American Journal of Psychiatry 1996;153:1128-1130.
67 Vandenberg SC, Singer SM, Pauls DL.
The Heredity of Behavior Disorders in Adults and Children.
New York: Plenum 1986.
68 Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, e Coll.
High risk for attention deficit hyperactivity disorder among children of
parents with childhood onset of the disorder: a pilot study.
American Journal of Psychiatry 1995;152:431-435.
69 LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL.
Dopamine D4 receptor gene polymorphism is associated with attention deficit
hyperactivity disorder.
Molecular Psychiatry 1996;1:12-124.
70 Swanson JM, Sunhoara GA, Kennedy JL, Regino R, Fineberg E, Wigal T.
Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype
of attention-deficit hyperactivity disorder (ADHD): a family-based approach.
molecular.
Molecular Psychiatry 1998;3:38-41.
71 Teicher NH, Baldessarini RJ.
Developmental pharmacodynamics.
In: Psychiatric Pharmacosciences of Children and Adolescents. Washington,
DC: American Psychiatric Press 1987:45-80.
72 Zametkin AJ, Rapoport JL.
Neurobiology of attention deficit disorder with hyperactivity: where have
we come in 50 years?
Journal of the American Academy of Child and Adolescent Psychiatry 1987;26:676-686.
73 Voeller KKS.
Right-hemisphere deficit syndrome in children.
American Journal of Psychiatry 1986;143:1004-1009.
74 Gordon I.
Cerabral blood flow imaging in pediatrics: a review.
Nuclear Medicine Communications 1996;17:1021-1029.
75 Lou HC, Henriksen L, Bruhn P, e Coll.
Striatal dysfunction in attention deficit and hyperkinetic disorder.
Archives of Neurology 1989;46:48-52.
76 Ernst M, Zametkin AJ, Phillips RL, Cohen RM.
Age-related in brain glucose metabolism in adults with attention deficit
hyperactivity disorder and control subjects.
Journal of Neuropsychiatry and Clinical Neurosciences 1998;10:168-177.
77 Lazar JW, Frank Y.
Frontal systems dysfunction in children with attention deficit hyperactivity
disorder and learning disabilities.
Journal of Neuropsychiatry and Clinical Neurosciences 1998;10:160-167.
78 Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D,
e Coll.
Quantitative morphology of the caudate nucleus in attention deficit hyperactivity
disorder.
American Journal of Psychiatry 1994;151:1791-1796.
79 Castellanos FX, Gedd JN, Marsh WL e Coll.
Quantitative brain magnetic resonance imaging in Attention-deficit/hyperactivity
disorder.
Archives of General Psychiatry 1996;53:607-616.
80 Rund BR, Oie M, Sundet K.
Back-ward masking in adolescents with schizophrenic disorders or attention-deficit/hyperactivity
disorder.
American Journal of Psychiatry 1996;153:1154-1157.
81 Jensen PS, Mrazek D, Knapp PK, Steinberg L, Pfeffer C, Schowalter J, e Coll.
Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation.
Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1672-1679.
82 Nelson KB, Ellenberg JH.
Antecedents of cerebral palsy: multivariate analysis of risk.
New England Journal of Medicine 1986;315:81-86.
83 Nichols PL, Chen T-C.
Minimal Brain Dysfunction: a Prospective Study.
Hillsdale, Nj: Lawrence Erlbaum 1981.
84 Bellinger D, Levitch A, Waternaux C, e Coll.
Longitudinal analyses of prenatal and postnatal lead exposure and early
cognitive development.
New England Journal Medicine 1987;316:1037-1043.
85 Milberger S, Biederman J, Faraone SV, Chen L, Jones J.
Is maternal smoking during pregnancy a risk factor for attention-deficit/hyperactivity
disorder in children?
American Journal Psychiatry 1996;153:1138-1142.
86 Rapport MD.
Response to letter to the editor.
Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1559.
87 Taylor E e Hemsley R.
Treating hyperkinetic disorders in childhood.
BMJ 1995;310:1617-1618.
88 Green WH.
Child and Adolescent Clinical Psychopharmacology.
Baltimore, MD: Williams & Wilkins 1991.
89 Greenhill LL.
Attention-deficit hyperactivity disorder: the stimulants.
Child and Adolescent Psychiatry Clinics of North America 1995;4:123-168.
90 Greenhill LL, Osman BB.
Ritalin: theory and patient management.
New York: Mary Ann Liebert 1991.
91 Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M.
Prediction of clinical response to methylphenidate in children with attention-deficit/hyperactivity
disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1995;8:1025-1032.
92 Amen DG, Goldman B.
Attention-deficit disorder: A guide for primary care phycians.
Primary Psychiatry 1998;5:76-85.
93 Safer DJ.
Relative cardiovascular safety of psychostimulants used in treatment of
attention-deficit hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;2:279-290.
94 Elia J, Borcherding BG, Rapoport Jl, Keysor CS.
Methylphenidate and dextroamphetamine treat of hypearctivity: are there
true non-responders?
Psychiatry Research 1991;36:141-155.
95 Rapport MD, Jones Jt, DuPaul GJ, e Coll.
Attention deficit disorder and methylphenidate: group and single-subject
analyses of dose effects on attention in clinic and in classroom setting.
Journal of Clinical Child Psychology 1987;16:329-338.
96 Spencer T, Biederman, Wilens T, Harding M, ODonnell D, Griffin S.
Pharmachotherapy of attention-deficit hyperactivity disorder across the
life cycle.
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:409-432.
97 Hinshaw SP, Heller T, McHale JP.
Covert antisocial behavior in boys with ttention deficit hyperactivity
disorder: external validation and effects of methylphenidate.
Journal of Consulting and Clinical Psychology 1992;60:274-281.
98 Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S.
Clinical efficacy of methylphenidate in conduct disorder with and withouth
attention deficit hyperactivity disorder.
Archives of General Psychiatry 1997;54:1073-1080.
99 Livingston RL, Dykman RA, Ackerman PT.
Psychiatric comorbidity and response to two doses of methylphenidate in
children with attention deficit hyperactivity disorder.
Journal of Child and Adolescent Psychopharmacology 1992;2:115-122.
100 Thomson JB, Varley CK.
Prediction of stimulant response in children with attention deficit hyperactivity
disorder.
Journal of Child Adolescent Psychopharmacology 1998;8:125-132.
101 Aman MG, Kern RA, Mc Ghee DE, Arnold LE.
Fenfluramine and metylphenidate in children with mental retardation and
ADHD: clinical and side effects.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:851-859.
102 Handen BL, Breaux AM, JanoskyJ, McAuliffe S, Feldman H, Gosling A
Effects and non-effects of methylphenidate in children with mental retardation
and ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31:455-461.
103 Klein RG.
The role of methylphenidate in psychiatry.
Archives of General Psychiatry 1995;52:429-433.
104 Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K.
A double-blind, crossover comparison of Methylphenidate and palcebo in
adults with childhood-onset Attention-deficit hyperactivity disorder.
Archives of General Psychiatry 1995;52:434-443.
105 Sprafkin J, Gadow KD.
Double-blind versus open evaluations of stimulant drug response in children
with Attention-deficit hyperactivity disorder.
Journal of Child and Adolescent Psychopharmachology 1996;6(4):215-228.
106 Gadow RD, Sverd J, Sprafkin J, Nolan EE, Ezor SN.
Efficacy of methylphenidate for attention-deficit/hyperactivity disorder
in children with tic disorder.
Archives of General Psychiatry 1995;52:444-455.
107 Rapoport JL, Buchsbaurn MS, Weingartner H, e Coll.
Dextroamphetamine: its cognitive and behavioral effects in normal and hyperactive
boys and normal men.
Archives of General Psychiatry 1980;37:933-943.
108 Hunt RD, Capper L, OConnell P.
Clonidine in child and adolescent psychiatry.
Journal of Child and Adolescent Psycopharmacology 1990;l:87-102.
109 Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A.
Comparision of clonidine response in the treatment of attentio-deficit
hyperactivity disorder with and without comorbid tic disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:350-353.
110 Cantwell DP, Baker L.
Stability and natural history of DSM-III childhood diagnoses.
Journal of the American Academy of Child and Adolescent Psychiatry 1989;28:691-700.
111 Popper CW, Elliot GR.
Sudden death and tricyclic antidepressants: clinical considerations for
children.
Journal of Child and Adolescent Psychopharrnacology 1990;l:125-132.
112 Riddle MA, Nelson JC, Kleinman CS, e Coll.
Sudden death in children receiving Norpramine: a review of three reported
cases and commentary.
Journal of the American Academy of Child and Adolescent Psychiatry 1991;30:104-108.
113 Klee BJ, Hack S, Green WH.
Tricyclic antidepressants in child and adolescent psychiatry: indications,
use and safety.
Primary Psychiatry 1998;5:86-90.
114 Biederman J, Baldessarini RJ, Wright V, Faraone SV, Keenan K.
A double-blind placebo controlled study of desipramine in the treatment
of ADD: III. Lack of impact of comorbidity and family history factors on clinical
response.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:199-204.
115 Wilens TE, Biederman J, Prince J.
Six-week, double-blind, placebo-controlled study of desipramine for adult
attention deficit hyperactivity disorder.
American Journal of Psychiatry 1996;153:1147-1153.
116 Trott GE, Friese HJ, Menzel M, Nissen G.
Use of moclobemide in children with attention deficit hyperactivity disorder.
Psychopharmacology 1992;106:S134-S136.
117 Schatzberg AF, Cole JO.
Manual of Clinical Psychopharmacology.
Washington: American Psychiatric Press 1991.
118 Pleak RR, Gormly LJ.
Effects of venlafaxine treatment for ADHD in a child.
Americn Journal of Psychiatry 1995;152:1099.
119 Wilens TE, Biederman J, Spencer T.
Venlafaxine for adult ADHD.
American Journal of Psychiatry 1995;152:7,1099.
120 Malhorta S, Santosh PJ.
An open trial of buspirone in children with attention-deficit/hyperactivity
disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1998;37:364-371.
121 Gammon GD, Brown TE.
Fluoxetine and metylphenidate in combination for treatment of attention-deficit
hyperactivity disorder and comorbid depressive disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;3:1-10.
122 Linsday DeVane C, Sallee F.
Serotonin reuptake inhibitors in child and adolescent psychopharmachology:
a review of published experience.
Journal of Clinical Psychiatry 1996;57:55-66.
123 Satterfield JH, Satterfield BT, Cantwell DP.
Three-year multimodality treatment study of 100 hyperactive boys.
Journal of Pediatrics 1981;98:650-655.
124 Elia J, Ambrosini PJ, Rapoport JL.
Treatment of Attention-Deficit-Hyperactivity Disorder.
The New England Journal of Medicine 1999;340:780-788.
125 NIMH Collaborative Multimodal Treatment Study of Children With ADHD (the
MTA).
Archives of General Psychiatry 1997;54:865-870.